Welcome to our dedicated page for AEHR TEST SYSTEMS SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AEHR TEST SYSTEMS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AEHR TEST SYSTEMS's regulatory disclosures and financial reporting.
AEHR TEST SYSTEMS EVP Alberto Salamone reported two open-market sales of common stock. He sold 15,000 shares at $94.56 on April 21, 2026 and 15,000 shares at $89.57 on April 20, 2026, totaling 30,000 shares sold.
After these sales, he directly holds 48,025 shares of AEHR common stock. A footnote states this amount includes shares subject to unvested restricted stock units, meaning part of his reported holdings are still vesting over time.
Aehr Test Systems director Howard T. Slayen reported a charitable stock gift. He transferred 1,800 shares of Common Stock as a bona fide gift at a stated price of $0.00 per share. The shares were donated to a Donor Advised Charitable Giving Fund.
After the gift, Slayen directly owns 176,528 shares of Aehr Test Systems common stock, and this amount includes shares subject to unvested restricted stock units. The filing shows no option exercises or open-market stock purchases or sales, only this charitable transfer.
AEHR insider Rhea Posedel reported multiple sales of common stock in April 2026 as disclosed on a Form 144. The filing lists individual trades including 30,000 shares on 04/09/2026 for $2,100,000 and other April trades with proceeds shown for each date. The filing also shows previously issued shares from compensation (604 shares, 10/20/2020) and an ESOP award (17,115 shares, 06/02/2025).
Alistair Sporck reported sales of Common Stock of Charles Schwab Corp. under a Rule 144 notice. The filing lists three transactions: 3,000 shares sold on 02/09/2026 for $82,716, 2,000 shares sold on 04/10/2026 for $134,730, and 2,000 shares sold on 04/16/2026 for $163,760.
The form also lists shares associated with an Employee Stock Purchase Plan dated 04/01/2024 (1,181 shares) and 10/01/2024 (819 shares) via payroll deductions.
Aehr Test Systems director Geoffrey Scott reported net open-market sales of 60,000 shares of Common Stock. Entities associated with him sold 50,000 shares at $95.00 per share through his spouse and 10,000 shares at $91.00 per share through a trust.
Following these transactions, he reports 52,864 shares held directly, 50,000 shares held indirectly by his spouse, and 50,686 shares held indirectly by a trust. The reported amounts include shares subject to unvested restricted stock units.
Aehr Test Systems executive Vernon Rogers sold 5,000 shares of Common Stock in an open-market transaction at $90.00 per share. After the sale, he directly holds 147,716 shares, which the disclosure states include shares subject to unvested restricted stock units. The transaction represents a small portion of his reported holdings and reflects a routine sale by the company’s Executive Vice President of Sales & Marketing.
Aehr Test Systems director Rhea J. Posedel reported an open-market sale of 8,787 shares of Common Stock at an average price of $96.0233 per share. The transaction occurred on April 21, 2026 and was recorded as a non-derivative sale.
Following the sale, she directly holds 62,376 Aehr shares. A separate indirect holding entry shows 396,979 shares held by a trust, and a footnote explains that this amount includes shares subject to unvested restricted stock units.
Aehr Test Systems executive vice president of sales and marketing Vernon Rogers reported an open-market sale of 6,486 shares of Common Stock at $94.0904 per share on April 21, 2026.
After this transaction, he directly holds 152,716 shares, and this figure includes shares underlying unvested restricted stock units. The sale amounts to roughly a small single-digit percentage of his reported holdings.
AEHR Manufacturing reported proposed insider sales of common stock via Form 144. The filing shows Vernon Rogers listed proposed dispositions of 2,431 shares on 04/20/2026, 5,000 shares on 04/16/2026, and 10,888 shares on 04/10/2026, with dollar values provided for each transaction. The shares are identified as common stock and one entry references an ESOP as issuer-related.
AEHR Technologies reported multiple Form 144 sales of common stock by an insider. The filing lists transactions dated 02/13/2026 through 04/20/2026, showing individual sales of 13,998, 30,000, 15,000, 7,500, and 7,500 shares. The entries include gross proceeds for each sale.